Communications Medicine Study - Dempsey et al. (2024)
This peer-reviewed study validates an enzyme-based biosensor for lung cancer detection, highlighting LEAP as a scalable, cost-effective blood test, outperforming traditional biomarkers in early-stage detection. The study demonstrates the limitations of traditional biomarkers in early-stage lung cancer and presents LEAP as a scalable, cost-effective blood test using protease enzyme activity.
